metricas
covid
Buscar en
Neurology perspectives
Toda la web
Inicio Neurology perspectives Bilateral olfactory bulb enhancement in a case of COVID19 with anosmia
Información de la revista
Vol. 1. Núm. 3.
Páginas 187-188 (julio - septiembre 2021)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1602
Vol. 1. Núm. 3.
Páginas 187-188 (julio - septiembre 2021)
Scientific letter
Open Access
Bilateral olfactory bulb enhancement in a case of COVID19 with anosmia
Realce bilateral del bulbo olfatorio en un paciente con COVID-19 y anosmia
Visitas
1602
C. Castañeda-Cruz1, B. Talavera2,
Autor para correspondencia
, D. García-Azorín2, R. Sigüenza-González1, J. Trigo-López2, E. Martínez-Pías2, M. Rodríguez-Velasco1
1 Radiology Department. Hospital Clínico Universitario de Valladolid. Valladolid, Spain
2 Neurology Department. Hospital Clínico Universitario de Valladolid, Valladolid, Spain
Este artículo ha recibido

Under a Creative Commons license
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (1)
Texto completo
Case report

A 39-year-old man male presented to the emergency room with right periocular headache, different and more intense than his usual migraine; cough; pleuritic chest pain; anosmia and dysgeusia for three days. Auscultation revealed bibasal crackling rales with no other abnormal signs in the physical and neurological examination. His blood tests showed increased levels of D-dimer, interleukin 6, ferritin and C-reactive protein. The real-time reverse-transcriptase-polymerase-chain-reaction assay from oropharyngeal swab was positive for Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and serum antibody testing exhibited positive IgM and negative IgG antibodies versus SARS-CoV-2. Chest X-ray findings were described as bibasal opacities with associated interstitial pattern. The SARS-CoV-2 RT-PCR in cerebrospinal fluid (CSF) was negative and all the CSF parameters were within normal range. He was therefore diagnosed with bilateral COVID pneumonia. On the 10th day since the onset of symptoms, after a remarkable improvement of the clinic and completely recovery of the smell, a magnetic resonance imaging (MRI) was carried out. The MRI (Fig. 1) showed bilateral localized contrast enhancement in olfactory bulbs. Pathophysiology of anosmia in Covid-19 patients is yet unknown and the neurotropism of the virus is unclear.1–2 Enhancement of olfactory bulb could suggest focal neuropathy. In the present case, it was notable that image findings persisted longer in time regardless of the symptom’s remission.

Fig. 1.

Left: Brain MRI. T1-BRAVO Coronal slice with paramagnetic contrast. The white arrow (2) points the olfactory bulbs, showing bilateral contrast enhancement. Right: Brain MRI. T2/FLAIR Coronal slice. The white arrow (1) points the olfactory bulbs, showing bilateral T2 hyperintensity.

(0.19MB).
Compliance with Ethical Standards

This study was approved by the hospital Ethics Review Board (code PI:17-831)

The patient has given the written consent for participating and publication of its potential personal data.

Availability of data and material is available upon request by the corresponding author.

Authors' contributions

All authors contributed to the study conception and design. Material preparation and data collection were performed by Carlos Castañeda Cruz, Blanca Talavera, David García Azorín Rebeca Sigüenza González, Javier Trigo López, Enrique Martínez Pías and Margarita Rodríguez Velasco. The first draft of the manuscript was written by Carlos Castañeda Cruz and Blanca Talavera and all authors commented on previous versions of the manuscript. All authors drafted the work, revised it critically for important intellectual content and approved the final manuscript.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References
[1.]
K.C. Ng Kee Kwong, P.R. Mehta, G. Shukla, A.R. Mehta.
COVID-19, SARS and MERS: a neurological perspective.
J Clin Neurosci, 77 (2020), pp. 13-16
[2.]
M.F.V.V. Aragão, M.C. Leal, O.Q. Cartaxo Filho, T.M. Fonseca, M.M. Valença.
Anosmia in COVID-19 associated with injury to the olfactory bulbs evident on MRI.
AJNR Am J Neuroradiol, 41 (2020), pp. 1703-1706
Copyright © 2021. Sociedad Española de Neurología
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos